Oculus Innovative Sciences Announces Fiscal Third Quarter 2008 Quarterly Results and Clinical Update Feb 7, 2008
Oculus Innovative Sciences Announces Agreement with Animal Health International for North American Distribution of Microcyn(R)-Based Vetericyn(TM) Wound Spray Jan 29, 2008
Oculus Innovative Sciences Awarded Damages by Federal Court in Intellectual Property Rights Litigation Jan 24, 2008
Top-Line Data from Oculus Innovative Sciences' Phase II Trial to Be Presented at DFCon 08 (Diabetic Foot Global Conference) on March 14, 2008 Jan 22, 2008
Oculus Innovative Sciences Completes Patient Treatment and Follow-up in Its Phase II Clinical Trial in Mildly Infected Diabetic Foot Ulcers Jan 3, 2008
Oculus Innovative Sciences Announces Completion of Two Randomized Controlled Clinical Trials of Microcyn(R) Technology in China Dec 18, 2007
Oculus Innovative Sciences Completes Enrollment of Phase II Trial of Microcyn(R) Technology in Treatment of Mildly Infected Diabetic Foot Ulcers Dec 5, 2007
Oculus Innovative Sciences Wins Federal Court Ruling in Intellectual Property Rights Litigation Nov 19, 2007
